RxDoctor Payments Data

Jeffrey Johnson, MD

Family Medicine · Grant, MINPI 1588650527

Payments from drug & device makers

$345in general payments, 2019–2025

Across 26 payments — averaging $13.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$83
  • Sunovion Pharmaceuticals Inc.$61
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • Novo Nordisk$42
  • Neurocrine Biosciences, Inc.$35
  • Teva Pharmaceuticals USA, Inc.$25
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$345100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$345 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$1,133
Medicare patients
36
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide49$74,896
JardianceEmpagliflozin49$62,641
EliquisApixaban63$54,795
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$33,390
Spiriva RespimatTiotropium Bromide31$29,098
OzempicSemaglutide29$28,536
FarxigaDapagliflozin Propanediol17$18,097
JanuviaSitagliptin Phosphate12$12,680
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$9,167
SymbicortBudesonide/Formoterol Fumarate16$8,384
Atorvastatin Calcium490$6,993
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$6,846
Incruse ElliptaUmeclidinium Bromide13$6,699
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$5,051
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,464

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$83$54,79563 claims
Novo NordiskOzempic$42$28,53629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grant

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →